Thompson Coburn partner Olga Berson has been honored as a top intellectual property attorney in the 2026 edition of the Lawdragon 500 Leading Global IP Lawyers. The list recognizes legal professionals who are protecting innovation, defending brand integrity and leveraging the assets at the heart of their clients’ businesses.
Olga’s practice spans a wide range of technical areas, including biopharmaceuticals (small and large molecules), drug delivery systems, medical devices, analytical technologies, skincare and cosmetics, foods and nutraceuticals, and specialty chemicals. Olga collaborates closely with inventors and scientific experts, translating complex technical concepts into practical, effective legal strategies.
She also helps clients uncover licensing opportunities, streamline portfolios, and plan for product launches through internal patent audits and patent landscape analyses. With a nuanced understanding of the interplay between patent law and U.S. Food and Drug Administration (FDA) regulations, she provides actionable advice on freedom-to-operate strategies. Her litigation experience, including Hatch-Waxman Act and Biologics Price Competition and Innovation Act (BPCIA) cases, empowers her to anticipate and mitigate potential litigation risks proactively.
Recent highlights of Olga’s work include advising on the commercialization of a COVID-19 vaccine, supporting the acquisition of an immunology company, and evaluating patent portfolios in fields such as immunology, oncology, and neurodegenerative diseases. She has conducted patent landscape analyses to facilitate the launch of biosimilar versions of blockbuster monoclonal antibodies.
See the full list of honorees here.
